Notice of NICHD's participation on PAR-19-326, Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21 Clinical Trial Optional)

Notice Number: NOT-HD-19-027

Key Dates
Release Date: September 16, 2019

Related Announcements
PAR-19-326

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform potential applicants that the Eunice Kennedy Shriver National Institute of Child Health and Human Development is participating in PAR-19-326, "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21 Clinical Trial Optional)."

The following changes have been made to reflect NICHD's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

Fogarty International Center (FIC)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.989, 93.279, 93.242, 93.393, 93.394, 93.395, 93.399, 93.865

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contacts

Sonia Lee, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-594-4783
Email: [email protected]

Financial/Grants Management Contact(s)

Bryan Clark, MBA
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6975
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Sonia Lee, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-594-4783
Email: [email protected]